JANX
Janux Therapeutics (JANX)
$65
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$15.18
Daily low
$14.60
Price at open
$15.18
52 Week High
$62.30
52 Week Low
$14.60
Market cap
909.4M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
2.7M
P/E ratio
-9.03
Janux Therapeutics News
Details
Daily high
$15.18
Daily low
$14.60
Price at open
$15.18
52 Week High
$62.30
52 Week Low
$14.60
Market cap
909.4M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
2.7M
P/E ratio
-9.03